Cited by 328Amyotrophic Lateral Sclerosis ResearchNuclear Structure and FunctionCancer-related gene regulation

Arginine methylation next to the PY‐NLS modulates Transportin binding and nuclear import of FUS

Open access
Dormann, Dorothee, Madl, Tobias, Valori, Chiara F, Bentmann, Eva, Tahirovic, Sabina, Abou‐Ajram, Claudia, Kremmer, Elisabeth, Ansorge, Olaf +3 more·2012·The EMBO Journal

Abstract

Fused in sarcoma (FUS) is a nuclear protein that carries a proline-tyrosine nuclear localization signal (PY-NLS) and is imported into the nucleus via Transportin (TRN). Defects in nuclear import of FUS have been implicated in neurodegeneration, since mutations in the PY-NLS of FUS cause amyotrophic lateral sclerosis (ALS). Moreover, FUS is deposited in the cytosol in a subset of frontotemporal lobar degeneration (FTLD) patients. Here, we show that arginine methylation modulates nuclear import of FUS via a novel TRN-binding epitope. Chemical or genetic inhibition of arginine methylation restores TRN-mediated nuclear import of ALS-associated FUS mutants. The unmethylated arginine-glycine-glycine domain preceding the PY-NLS interacts with TRN and arginine methylation in this domain reduces TRN binding. Inclusions in ALS-FUS patients contain methylated FUS, while inclusions in FTLD-FUS patients are not methylated. Together with recent findings that FUS co-aggregates with two related proteins of the FET family and TRN in FTLD-FUS but not in ALS-FUS, our study provides evidence that these two diseases may be initiated by distinct pathomechanisms and implicates alterations in arginine methylation in pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emboj.2012.261

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The majority of disease-associated FUS mutations affect the C-terminal nuclear localization signal, resulting in cytosolic mislocalization and aggregation of mutant FUS.

    “The majority of disease-associated FUS mutations affect the C-terminal nuclear localization signal, resulting in cytosolic mislocalization and aggregation of mutant FUS [232–234].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dormann, D., Madl, T., Valori, C. F., Bentmann, E., Tahirovic, S., Abou‐Ajram, C., Kremmer, E., Ansorge, O., Mackenzie, I. R. A., Neumann, M., & Haass, C.
Affiliations
  • Adolf-Butenandt-Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie (DE)
  • University of Graz (AT)
  • German Center for Neurodegenerative Diseases (DE)
  • Helmholtz Munich (DE)
  • John Radcliffe Hospital (GB)
  • Vancouver General Hospital (CA)
Corresponding author
  • Dormann, Dorothee
  • Haass, Christian
Venue
The EMBO Journal
Published
2012-09-11
Volume
31
Issue
22
Pages
4258-4275
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2127899638
Cited by
326
References
78
Citations by year
2026: 14 · 2025: 13 · 2024: 21 · 2023: 20 · 2022: 23 · 2021: 42 · 2020: 27 · 2019: 20 · 2018: 31 · 2017: 18 · 2016: 29 · 2015: 26 · 2014: 15 · 2013: 23 · 2012: 4
FWCI
14.18
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
  • Site cant be reached (submittedVersion)
  • DZNE Pub (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • National Science Foundation
  • National Institute for Health and Care Research
  • Parkinson's UK (J-0901)
  • Robert Bosch Stiftung
  • Deutsche Forschungsgemeinschaft (Ma 5703/1–1, SFB 596)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (132864, 31003A, 179009)
  • Österreichischen Akademie der Wissenschaften
  • Bundesministerium für Bildung und Forschung
  • Hans und Ilse Breuer-Stiftung
  • Canadian Institutes of Health Research (74580, 179009)
  • Elitenetzwerk Bayern
  • NIHR Oxford Biomedical Research Centre
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
Keywords
FUS, arginine methylation, transportin, nuclear import, amyotrophic lateral sclerosis, frontotemporal lobar degeneration, protein aggregation, neurodegeneration
MeSH terms
Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Arginine, Cell Nucleus, HeLa Cells, Humans, Methylation, Molecular Sequence Data, Proline, Protein-Arginine N-Methyltransferases, Protein Binding, Repressor Proteins, Tyrosine, Signal Transduction, Nuclear Localization Signals, Gene Silencing, Active Transport, Cell Nucleus, Karyopherins, RNA-Binding Protein FUS, Frontotemporal Lobar Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review